As expected, this increase in phospho-CDK1 was suppressed by AZD1775 (Figure 3), showing that this inhibitor can effectively prevent the WEE1-mediated phosphorylation and inactivation of CDK1, which could thereby abrogate the dl922-947-induced DNA damage checkpoint in MM cell lines. The gene discussed is CDK1; the disease is Miyoshi myopathy.